Ensysce Biosciences annual operating margin
2020
2021
2022
2023
2024
2025
Ensysce Biosciences Operating Margin Growth & History (ENSC)
Ensysce Biosciences's operating margin was −202.12% for fiscal 2025.
View full Ensysce Biosciences company overviewEnsysce Biosciences annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −202.12% | −72.95 pp |
| 2024 | 2024-12-31 | −129.18% | +351.35 pp |
| 2023 | 2023-12-31 | −480.52% | +479.38 pp |
| 2022 | 2022-12-31 | −959.91% | −397.20 pp |
| 2021 | 2021-12-31 | −562.71% | −521.67 pp |
| 2020 | 2020-12-31 | −41.04% | — |
Ensysce Biosciences quarterly operating margin
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −221.28% | −93.64 pp |
| Q1 2026 | 2026-03-31 | −370.68% | −221.60 pp |
| Q4 2025 | 2025-12-31 | −147.79% | +126.56 pp |
| Q3 2025 | 2025-09-30 | −758.68% | −777.54 pp |
| Q2 2025 | 2025-06-30 | −127.64% | +947.98 pp |
| Q1 2025 | 2025-03-31 | −149.08% | +453.74 pp |
| Q4 2024 | 2024-12-31 | −274.34% | +338.37 pp |
| Q3 2024 | 2024-09-30 | 18.86% | +640.69 pp |
| Q2 2024 | 2024-06-30 | −1,075.62% | −607.92 pp |
| Q1 2024 | 2024-03-31 | −602.82% | −278.47 pp |
| Q4 2023 | 2023-12-31 | −612.71% | −180.14 pp |
| Q3 2023 | 2023-09-30 | −621.83% | +1584.47 pp |
| Q2 2023 | 2023-06-30 | −467.70% | +2932.86 pp |
| Q1 2023 | 2023-03-31 | −324.36% | +472.00 pp |
| Q4 2022 | 2022-12-31 | −432.57% | −307.41 pp |
| Q3 2022 | 2022-09-30 | −2,206.30% | −800.02 pp |
| Q2 2022 | 2022-06-30 | −3,400.56% | −3307.74 pp |
| Q1 2022 | 2022-03-31 | −796.36% | −587.13 pp |
| Q4 2021 | 2021-12-31 | −125.16% | −76.25 pp |
| Q3 2021 | 2021-09-30 | −1,406.28% | −1413.90 pp |
| Q2 2021 | 2021-06-30 | −92.82% | — |
| Q1 2021 | 2021-03-31 | −209.23% | — |
| Q3 2020 | 2020-09-30 | −48.91% | — |
| Q2 2020 | 2020-06-30 | 7.62% | — |
Ensysce Biosciences operating margin trends
Over the last five reported fiscal years, Ensysce Biosciences's operating margin decreased from −41.04% to −202.12%, a change of −161.09 percentage points. The latest reported quarter, Q2 2026, shows −221.28%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ensysce Biosciences filings at SEC.gov ↗